SM
Sabby Management Portfolio holdings
AUM
$13M
This Quarter Return
-0.2%
1 Year Return
-26.95%
3 Year Return
-56.43%
5 Year Return
-61.92%
10 Year Return
-71.17%
AUM
$156M
AUM Growth
+$156M
(+7.2%)
Cap. Flow
-$4.09M
Cap. Flow
% of AUM
-2.63%
Top 10 Holdings %
Top 10 Hldgs %
70.68%
Holding
160
New
45
Increased
11
Reduced
31
Closed
38
Top Buys
| 1 |
Biogen
BIIB
|
$50.1M |
| 2 |
SPDR S&P 500 ETF Trust
SPY
|
$11.7M |
| 3 |
Cogent Biosciences
COGT
|
$9.38M |
| 4 |
Incyte
INCY
|
$6.82M |
| 5 |
Nektar Therapeutics
NKTR
|
$4.13M |
Top Sells
| 1 |
Bristol-Myers Squibb
BMY
|
$57.4M |
| 2 |
Esperion Therapeutics
ESPR
|
$8.92M |
| 3 |
SELLAS Life Sciences
SLS
|
$7.99M |
| 4 |
ONCE
Spark Therapeutics, Inc. Common Stock
ONCE
|
$5.7M |
| 5 |
InspireMD
NSPR
|
$4.25M |
Sector Composition
| 1 | Healthcare | 86.15% |
| 2 | Consumer Staples | 2.32% |
| 3 | Consumer Discretionary | 0.64% |
| 4 | Materials | 0.5% |
| 5 | Technology | 0.45% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
SenesTech
SNES
$25.5M
| $405K | 0.05% |
794,740
+357,877
| +82% | +$182K |
|
52
XTI Aerospace
XTIA
$41.7M
| $394K | 0.05% |
+366,925
| New | +$394K |
|
|
ROSG
53
DELISTED
Rosetta Genomics Ltd.
ROSG
| $383K | 0.05% |
+934,608
| New | +$383K |
|
54
Merck
MRK
$212B
| $374K | 0.04% |
+6,864
| New | +$374K |
|
55
Strata Skin Sciences
SSKN
$9.3M
| $368K | 0.04% |
315,745
-19,360
| -6% | -$22.6K |
|
|
BIOA
56
DELISTED
BioAmber Inc.
BIOA
| $368K | 0.04% |
7,819,887
+7,798,568
| +36,580% | +$367K |
|
|
XLRN
57
DELISTED
Acceleron Pharma Inc.
XLRN
| $338K | 0.04% |
+8,646
| New | +$338K |
|
58
Traws Pharma
TRAW
$10.4M
| $334K | 0.04% |
399,580
-161,583
| -29% | -$135K |
|
59
Xenon Pharmaceuticals
XENE
$3.02B
| $328K | 0.04% |
67,000
-262,400
| -80% | -$1.28M |
|
|
EIGR
60
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
| $317K | 0.04% |
32,190
-16,810
| -34% | -$166K |
|
61
Insmed
INSM
$30.6B
| $300K | 0.04% |
+13,300
| New | +$300K |
|
62
Sonoma Pharmaceuticals
SNOA
$7.62M
| $255K | 0.03% |
+69,200
| New | +$255K |
|
|
63
InspireMD
NSPR
$100M
| $254K | 0.03% |
243,794
-4,078,115
| -94% | -$4.25M |
|
64
Axsome Therapeutics
AXSM
$6.11B
| $199K | 0.02% |
+81,159
| New | +$199K |
|
|
ONTXW
65
DELISTED
Onconova Therapeutics, Inc. Warrants
ONTXW
| $196K | 0.02% |
654,019
+10,775
| +2% | +$3.23K |
|
66
Solid Biosciences
SLDB
$432M
| $188K | 0.02% |
+25,000
| New | +$188K |
|
67
Abeona Therapeutics
ABEO
$356M
| $187K | 0.02% |
+12,998
| New | +$187K |
|
|
BPTH
68
DELISTED
Bio-Path Holdings Inc
BPTH
| $170K | 0.02% |
85,013
-1,748,436
| -95% | -$3.5M |
|
|
APDNW
69
DELISTED
Applied DNA Sciences Inc Warrant
APDNW
| $162K | 0.02% |
648,824
+6,535
| +1% | +$1.63K |
|
70
FuelCell Energy
FCEL
$92.1M
| $158K | 0.02% |
+91,400
| New | +$158K |
|
|
SGLBW
71
DELISTED
Sigma Labs, Inc. Warrant
SGLBW
| $142K | 0.02% |
375,718
-7,150
| -2% | -$2.7K |
|
|
EDAP
72
EDAP TMS
EDAP
$112M
| $141K | 0.02% |
+60,600
| New | +$141K |
|
73
VistaGen Therapeutics
VTGN
$110M
| $133K | 0.02% |
143,486
-1,972,387
| -93% | -$1.83M |
|
|
RXIIW
74
DELISTED
RXi Pharmaceuticals Corporation Warrants expiring 12/16/2021
RXIIW
| $88K | 0.01% |
196,522
-1,904,275
| -91% | -$853K |
|
|
FRTX
75
DELISTED
Fresh Tracks Therapeutics, Inc. Common Stock
FRTX
| $87K | 0.01% |
59,832
-215,258
| -78% | -$313K |
|